US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

Trans Care In Court: Gov't Probes, Forum Concerns And More No Photo Available

Gianna Ferrarin

Law360 Healthcare Authority looks at developments over the past week in legal challenges to probes by the Justice Department and Feder... (more story)

A Battle Bigger Than Abortion Pills On Deck At High Court No Photo Available

Dan McKay

The outcome of the latest abortion clash at the high court could reach well beyond mifepristone access and make other federal policy c... (more story)

This Week's Healthcare Earnings: Novo, Hims And More No Photo Available

Yeji Jesse Lee

The healthcare industry wrapped up its first-quarter earnings readouts this week, closing off the season with major names like Novo Nordisk and CVS.